Recce breathes better on positive lung infection drug pilot test results
Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
DBO | Ann: Appendix 5B - Quarterly Cash Flow Report | 06/05/24 | 2 | 483 | |||
|
|||||||
DBO | Ann: Notification of cessation of securities - DBO | 26/04/24 | 0 | 158 | |||
|
|||||||
DBO | Ann: Quarterly Activities Report | 19/04/24 | 0 | 142 | |||
|
|||||||
DBO | Ann: Letter to Shareholders | 15:18 | 4 | 1.6K | |||
|
|||||||
DBO | Ann: Becoming a substantial holder | 10:38 | 4 | 1.3K | |||
|
|||||||
DBO | Ann: Notification regarding unquoted securities - DBO | 15/03/24 | 0 | 216 | |||
|
|||||||
DBO | Ann: Half Year Financial Report - 31 December 2023 | 11/03/24 | 5 | 1.2K | |||
|
|||||||
DBO | Ann: Unmarketable Parcel Sale Facility | 07/02/24 | 2 | 1.2K | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |